Acceleran presents preclinical data for muscle therapeutics ACE-083 and ACE-2494
8 October 2015 | By Victoria White
Acceleron reported the results at the 20th International Annual Congress of the World Muscle Society (WMS)...
List view / Grid view
News
Two-hit approach shows promise in breast cancer study
8 October 2015 | By Victoria White
Researchers have eradicated a specific type of breast cancer tumour in mice by disabling a cancer-causing pathway and administering an immune-molecule based mop-up therapy...
Nektar submits IND for NKTR-214 to treat solid tumours
8 October 2015 | By Victoria White
NKTR-214 is a CD122-biased immune-stimulatory cytokine that is designed to stimulate the expansion and maintenance of CD8-positive effector T-cells...
Cancer Research UK invests £15m to develop new cancer treatments
7 October 2015 | By Victoria White
The Cancer Research UK Centres Network Accelerator Award provides infrastructure support to research centres in order to encourage collaboration between different organisations and boost ‘bench to bedside’ science...
C4XD provides a research update on its IL-17 targeting leads
7 October 2015 | By Victoria White
C4XD’s most advanced compound, an oral Orexin-1 antagonist for the treatment of addiction, is in formal preclinical safety and toxicity studies...
Cell Therapy Catapult launches the Cell History File
7 October 2015 | By Victoria White
The Cell History File has been designed to fulfil the role of a ‘cell passport’ that can accompany a tissue or cell derived product as it progresses through various processing stages...
Global and USA Biosimilar Market: Latest updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim
7 October 2015 | By SMi Group
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...
Horizon Discovery Group in-licenses oncology programme from Servier
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
Discovery could transform rheumatoid arthritis patient care
6 October 2015 | By Victoria White
Cardiff University immunologists have described how an immune system protein - interleukin-27 - regulates the inflammatory process in lymphoid-rich rheumatoid arthritis...
Adaptimmune to expand its R&D operation in Oxfordshire
6 October 2015 | By Victoria White
The new building is designed to support the Company’s continuing growth of its research and development operation and is scheduled for delivery in late 2016...
Non-therapeutic applications to add revenue to the global human albumin market
6 October 2015 | By Victoria White
Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...
Gene therapy shows success in vision loss mitochondrial disease
6 October 2015 | By Victoria White
Researchers have found that they can use gene therapy to improve visual in mice models for the vision disorder Leber hereditary optic neuropathy (LHON)...
Targeting cancer’s nutrient seeking protein could restrict growth
5 October 2015 | By Victoria White
Initial studies by Oxford University researchers show that targeting the protein, called PAT4, could restrict cancerous cells' ability to grow...
Cancer drug RGFP966 appears to sharpen memory
5 October 2015 | By Victoria White
Rats given RGFP966 were more attuned to what they were hearing and were able to retain and remember more information...
Nobel Prize recognises discoveries in parasitic diseases
5 October 2015 | By Victoria White
The Nobel Prize for Physiology or Medicine has been split this year to recognise work that has revolutionised the treatment of some parasitic diseases...
